Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Epigenomics ADR?
Epigenomics ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -110.08. EPS indicates the company's profitability on a per-share basis.
What is Epigenomics ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Epigenomics ADR reported a revenue of $616.22K.
What is the EBITDA for Epigenomics ADR?
Epigenomics ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$16.64M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Epigenomics ADR?
Epigenomics ADR has a free cash flow of -$15.29M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Epigenomics ADR have, and what sector and industry does it belong to?
Epigenomics ADR employs approximately 34 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- EPS (TTM)
- -110.08
- Revenue (TTM)
- $616.22K
- EBITDA (TTM)
- -$16.64M
- Free Cashflow (TTM)
- -$15.29M
Information
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
- Employees
- 34
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- ECX2
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet